Related Experiment Video
Updated: Jan 23, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Silencing PAR-2 in macrophages promotes PANoptosis and triggers duodenal microinflammation in functional dyspepsia
Liping Wu1, Zhiming Wang1, Shiyan Wu2
1Department of Gastroenterology, The Third People's Hospital of Chengdu, Chengdu 610031, Sichuan, China.
Abstract:
Macrophage PANoptosis may play a critical role in the development of functional dyspepsia (FD). It not only affects the balance and regulation of the immune system but also participates in the pathogenesis of FD, possibly by affecting the motor and sensory functions of the gastrointestinal tract. In this study, key genes related to PANoptosis and macrophages were identified using weighted gene co-expression network analysis (WGCNA) and Mendelian randomization. Their function was further explored through gene set enrichment analysis (GSEA). In vivo and in vitro experiments were conducted to examine the role of macrophages in FD duodenal micro-inflammation and the involvement of key genes in macrophage PANoptosis. A total of 489 target genes were identified by intersecting 1537 differentially expressed genes with 10,436 PANoptosis-related module genes. Among them, ARL5B, CAPN3, CDK5RAP3, and F2RL1 showed a causal relationship with FD. Functional enrichment results revealed that these key genes, particularly PAR-2, are involved in NF-κB, AMPK, Toll-like receptors, and other signaling pathways. Moreover, this study showed that silencing PAR-2 in macrophages promoted PANoptosis and triggered duodenal micro-inflammation in FD. These findings suggest that the NF-κB-PAR-2 axis may serve as a central regulatory mechanism that plays an important role. This study offers novel insights and potential targets for the clinical diagnosis and treatment of FD.
Insights
Macrophage PANoptosis is implicated in functional dyspepsia (FD) pathogenesis. Targeting the NF-κB-PAR-2 axis in macrophages may offer new therapeutic strategies for FD.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Macrophage PANoptosis is increasingly recognized for its role in immune system regulation and inflammatory diseases.
- Functional dyspepsia (FD) involves complex immune dysregulation potentially linked to macrophage activity and gastrointestinal dysfunction.
Purpose of the Study:
- To identify key genes involved in macrophage PANoptosis and their causal relationship with functional dyspepsia (FD).
- To elucidate the role of these genes and associated pathways in duodenal micro-inflammation in FD.
- To explore the NF-κB-PAR-2 axis as a potential therapeutic target for FD.
Main Methods:
- Weighted gene co-expression network analysis (WGCNA) and Mendelian randomization were used to identify key genes.
- Gene set enrichment analysis (GSEA) explored gene functions and pathways.
- In vivo and in vitro experiments assessed macrophage PANoptosis and duodenal micro-inflammation in FD models.
Main Results:
- 489 target genes were identified, with ARL5B, CAPN3, CDK5RAP3, and F2RL1 showing a causal link to FD.
- Key genes, especially PAR-2, are involved in NF-κB, AMPK, and Toll-like receptor signaling pathways.
- Silencing PAR-2 in macrophages exacerbated PANoptosis and induced duodenal micro-inflammation in FD.
Conclusions:
- The NF-κB-PAR-2 axis is a central regulatory mechanism in macrophage-mediated duodenal micro-inflammation in FD.
- Targeting macrophage PANoptosis and the NF-κB-PAR-2 axis presents potential therapeutic avenues for FD.
- This study provides novel insights into the pathogenesis of FD and identifies potential diagnostic and therapeutic targets.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Anaphase Promoting Complex
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...

